miR-92a-3p is a known oncogene in other cancer and its role in PDAC has only been shown in pancreatic cancer cells where it targets JNK signaling pathway inhibitor, DUSP10 and promote JNK signaling and tumorigenesis. This evidence concerns the gene MAPK8 and familial pancreatic carcinoma.